Surgeons. Dr. Belldegrun
Chair of the BoardatAllogene Therapeutics· In the 2023 proxy
Surgeons. Dr. Belldegrun is Chair of the Board of Allogene Therapeutics.
Experience
- Allogene TherapeuticsPublic company · 3 yr
- Chair of the Board2023 – Present · 3 yrStock in role -77%
Roles come from the proxy statements of each company.
Activity
No new filings about this person in the feed.
Two people shown as one, or a wrong number?